Evidence map›Paper›PMID 39859369›Full record

ArticleInternational journal of molecular sciences2025

Methanolic Leaves Extract of

Sumayyah Saeed, Arij Fouzat Hassan, Azza Suliman, Ala-Eddin Al Moustafa, Feras Alali

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sumayyah SaeedCollege of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.
Arij Fouzat HassanCollege of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.ORCID 0000-0002-2012-4153
Azza SulimanCollege of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.
Ala-Eddin Al MoustafaCollege of Medicine, QU Health, Qatar University, Doha 2713, Qatar.ORCID 0000-0003-4452-3439
Feras AlaliCollege of Pharmacy, QU Health, Qatar University, Doha 2713, Qatar.ORCID 0000-0001-8624-6869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human epidermal growth factor receptor 2 (HER2) is a subtype of breast cancer that is associated with poor prognosis and low survival rates. The discovery of novel anti-cancer agents to manage this subtype of cancer is still needed.

Indexed as

Breast NeoplasmsCell MovementErb-b2 Receptor Tyrosine KinasesMAP Kinase Signaling Systemp38 Mitogen-Activated Protein KinasesPlant ExtractsPlant LeavesZiziphusAnimalsApoptosisCell Line, TumorCell ProliferationCell SurvivalFemaleHumansMethanolERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesMethanolp38 Mitogen-Activated Protein KinasesPlant Extractsanti-cancerHER2-positive breast cancerquercetinrutinZiziphus spina-christi

Identifiers

PMID39859369
PMCPMC11765879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.